These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7655490)

  • 1. Antiphospholipid syndrome and the idiotypic network.
    Bakimer R; Blank M; Kosashvilli D; Ichikawa K; Khamashta MA; Hughes GR; Koike T; Shoenfeld Y
    Lupus; 1995 Jun; 4(3):204-8. PubMed ID: 7655490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome.
    Yodfat O; Blank M; Krause I; Shoenfeld Y
    Clin Immunol Immunopathol; 1996 Jan; 78(1):14-20. PubMed ID: 8599879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network.
    Cohen J; Bakimer R; Blank M; Valesini G; Shoenfeld Y
    Ann Rheum Dis; 1993 Oct; 52(10):742-8. PubMed ID: 8257211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.
    Sthoeger ZM; Tartakovsky B; Bentwich Z; Mozes E
    J Clin Immunol; 1993 Mar; 13(2):127-38. PubMed ID: 7686561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.
    Blank M; Faden D; Tincani A; Kopolovic J; Goldberg I; Gilburd B; Allegri F; Balestrieri G; Valesini G; Shoenfeld Y
    J Autoimmun; 1994 Aug; 7(4):441-55. PubMed ID: 7980847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS.
    Levy Y; Sherer Y; Mathieu A; Cauli A; Passiu G; Sanna G; Janackovic Z; Blank M; Shoenfeld Y
    Clin Exp Rheumatol; 2000; 18(4):479-84. PubMed ID: 10949723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.
    Blank M; Krause I; Ben-Bassat M; Shoenfeld Y
    J Autoimmun; 1992 Aug; 5(4):495-509. PubMed ID: 1418290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
    Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
    J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.
    Cohen J; Bakimer R; Blank M; Valesini G; Shoenfeld Y
    Clin Exp Immunol; 1994 Aug; 97(2):181-6. PubMed ID: 8050164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).
    Bakimer R; Fishman P; Blank M; Sredni B; Djaldetti M; Shoenfeld Y
    J Clin Invest; 1992 May; 89(5):1558-63. PubMed ID: 1569194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies.
    Blank M; Tincani A; Shoenfeld Y
    J Rheumatol; 1994 Jan; 21(1):100-4. PubMed ID: 8151562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice.
    Krause I; Blank M; Shoenfeld Y
    J Clin Immunol; 1998 Jan; 18(1):52-60. PubMed ID: 9475354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS).
    George J; Blank M; Hojnik M; Bar-Meir E; Koike T; Matsuura E; Lorber M; Aviram M; Shoenfeld Y
    Clin Exp Immunol; 1997 May; 108(2):227-33. PubMed ID: 9158090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell.
    Blank M; Krause I; Lanir N; Vardi P; Gilburd B; Tincani A; Tomer Y; Shoenfeld Y
    Arthritis Rheum; 1995 Jan; 38(1):115-22. PubMed ID: 7818560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of experimental primary and secondary antiphospholipid syndromes in naive mice.
    Shoenfeld Y
    Am J Reprod Immunol; 1992; 28(3-4):219-21. PubMed ID: 1285883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
    Blank M; Waisman A; Mozes E; Koike T; Shoenfeld Y
    Int Immunol; 1999 Dec; 11(12):1917-26. PubMed ID: 10590257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
    Hörkkö S; Miller E; Dudl E; Reaven P; Curtiss LK; Zvaifler NJ; Terkeltaub R; Pierangeli SS; Branch DW; Palinski W; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):815-25. PubMed ID: 8698874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies.
    Tomer Y; Blank M; Shoenfeld Y
    Arthritis Rheum; 1994 Aug; 37(8):1236-44. PubMed ID: 7914411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.